169 related articles for article (PubMed ID: 32567368)
1. Eyelid sebaceous gland carcinoma: An assessment of the T classification of the American Joint Committee of Cancer TNM staging system 8th versus 7th edition.
AlHammad F; Edward DP; Alkatan HM; Elkhamary S; Iuliano A; Maktabi A; Al-Horani SE; Al-Sheikh O; Al Hussain H; Strianese D
Eur J Ophthalmol; 2021 Jul; 31(4):2055-2063. PubMed ID: 32567368
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients.
Sa HS; Rubin ML; Xu S; Ning J; Tetzlaff M; Sagiv O; Kandl TJ; Esmaeli B
Br J Ophthalmol; 2019 Jul; 103(7):980-984. PubMed ID: 30131380
[TBL] [Abstract][Full Text] [Related]
3. Eyelid sebaceous gland carcinoma, validation of AJCC 8th edition T staging- a retrospective study from North India.
Sen S; Bhardwaj M; Jayaraj P; Bakhshi S; Pushker N; Kashyap S; Bajaj MS; Khandpur S
Acta Ophthalmol; 2023 Feb; 101(1):49-56. PubMed ID: 35751173
[TBL] [Abstract][Full Text] [Related]
4. Eyelid sebaceous carcinoma: Validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival.
Hsia Y; Yeh CY; Wei YH; Chen LW; Liao SL
Eye (Lond); 2019 Jun; 33(6):887-895. PubMed ID: 31147618
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of the Staging System for Eyelid Tumors in the 7th Edition of the American Joint Committee on Cancer Staging Manual.
Ford J; Thakar S; Thuro B; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2017; 33(5):317-324. PubMed ID: 28350693
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
7. Change in Eyelid Carcinoma T Category With Use of the 8th Versus 7th Edition of the American Joint Committee on Cancer: Cancer Staging Manual.
Ding S; Sagiv O; Guo Y; Kandl TJ; Thakar SD; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2019; 35(1):38-41. PubMed ID: 29877957
[TBL] [Abstract][Full Text] [Related]
8. American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival.
Esmaeli B; Nasser QJ; Cruz H; Fellman M; Warneke CL; Ivan D
Ophthalmology; 2012 May; 119(5):1078-82. PubMed ID: 22330966
[TBL] [Abstract][Full Text] [Related]
9. Sebaceous gland carcinoma: analysis based on the 8
Morawala A; Mohamed A; Krishnamurthy A; Jajapuram SD; Kaliki S
Eye (Lond); 2023 Mar; 37(4):714-719. PubMed ID: 35347292
[TBL] [Abstract][Full Text] [Related]
10. Validation Study of the AJCC Cancer Staging Manual, Eighth Edition, Staging System for Eyelid and Periocular Squamous Cell Carcinoma.
Xu S; Sagiv O; Rubin ML; Sa HS; Tetzlaff MT; Nagarajan P; Ning J; Esmaeli B
JAMA Ophthalmol; 2019 May; 137(5):537-542. PubMed ID: 30869769
[TBL] [Abstract][Full Text] [Related]
11. Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma.
Sa HS; Rubin ML; Ning J; Li W; Tetzlaff MT; McGovern SL; Paulino AC; Herzog CE; Gill JB; Esmaeli B
JAMA Ophthalmol; 2020 Apr; 138(4):374-381. PubMed ID: 32105303
[TBL] [Abstract][Full Text] [Related]
12. Differences in 7th and 8th edition American Joint Committee on Cancer staging for periocular sebaceous carcinoma.
Reynolds RR; Davies MJ; Buffam FV; Dolman PJ; White VA
Can J Ophthalmol; 2021 Feb; 56(1):31-36. PubMed ID: 32822657
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification.
Kaliki S; Gupta A; Ali MH; Ayyar A; Naik MN
Int Ophthalmol; 2016 Oct; 36(5):681-90. PubMed ID: 26830096
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection.
Park S; Choi S; Cho YA; Sinn DH; Kim JM; Park CK; Ha SY
Cancer Res Treat; 2020 Oct; 52(4):1145-1152. PubMed ID: 32599989
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
[TBL] [Abstract][Full Text] [Related]
16. Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: Results from a non-endemic cohort with 10-year follow-up.
Wu LR; Zhang XM; Xie XD; Lu Y; Wu JF; He X
Oral Oncol; 2019 Nov; 98():141-146. PubMed ID: 31586896
[TBL] [Abstract][Full Text] [Related]
17. Validation of the 8th edition of the AJCC/UICC TNM staging system for tongue squamous cell carcinoma.
Kano S; Sakashita T; Tsushima N; Mizumachi T; Nakazono A; Suzuki T; Yasukawa S; Homma A
Int J Clin Oncol; 2018 Oct; 23(5):844-850. PubMed ID: 29675646
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System.
Lee JW; Lee JH; Park Y; Lee W; Kwon J; Song KB; Hwang DW; Kim SC
Cancer Res Treat; 2020 Jul; 52(3):886-895. PubMed ID: 32164049
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea.
Choi YJ; Jin HC; Lee MJ; Kim N; Choung HK; Khwarg SI
Jpn J Ophthalmol; 2014 Jul; 58(4):327-33. PubMed ID: 24763914
[TBL] [Abstract][Full Text] [Related]
20. Need to restage Korean melanoma patients following publication of the 8th edition of the American Joint Committee on Cancer staging manual.
Lee HJ; Park KD; Jang YH; Lee WJ; Lee SJ; Kim JY
Indian J Dermatol Venereol Leprol; 2022; 88(3):332-336. PubMed ID: 34491680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
